Regeneron Pharmaceuticals (REGN)

Other Income/Expenses (Net)

$1.20B

TTM · Period ending: · USD

REGN logo

REGN Other Income/Expenses (Net)

Latest reported$1.20B
REGN TTM Other Income/Expenses (Net) ($0.00 → $1.20B)
High-resolution chart · PNG

REGN other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
1,195,900,000
1,527,800,000
1,652,800,000
1,456,900,000
1,033,900,000
1,153,200,000
789,200,000
918,200,000
504,500,000
12,400,000
-81,700,000
-169,300,000
217,000,000
-193,100,000
-273,800,000
-419,400,000
-736,100,000
13,200,000
379,000,000
572,900,000
548,700,001
405,600,001
233,800,001
390,300,001
475,100,000
121,700,000
219,300,000
-36,700,000
-57,762,000
67,024,000
19,091,000
76,947,000
73,688,000
15,340,000
-1,080,000
-22,512,000
-25,112,000
-22,000
-926,000
757,000
-1,455,000
-18,946,000
-26,819,000
-49,106,000
-56,614,000
-59,038,000
-62,684,000
-50,524,000
-55,001,000
-46,125,000
-46,668,000
-43,859,000
-43,637,000
-46,761,000
-46,092,000
-43,637,000
-36,087,000
-25,601,000
-17,733,000
-6,326,000
-4,761,000
-3,462,000
-2,425,000
-6,379,000
-4,322,000
-1,244,000
2,151,000
5,707,000
7,326,000
25,617,000
39,778,000
26,855,000
27,789,000
12,000,000
-179,000
-59,273,000
-61,255,000
-64,412,000
-26,101,000
32,170,000
100,362,000
158,855,000
116,812,000
117,862,000
69,378,000
37,404,000
78,142,000
84,891,000
90,039,000
118,515,000
136,266,000
134,220,000
140,694,000
114,976,000
81,680,000
80,963,000
72,080,000
60,215,000
49,733,000
65,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.